Sign inGet started

Maddux Randy Joe

Insider CIK 1683826 · IBIO Chief Operating Officer · APVO Senior VP, Operations

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IBIO, INC. iBio, Inc. S Sale2021-12-072022-03-1437,243$0.68 $25.3K271,757SEC↗
IBIO iBio, Inc. A Award deriv2021-08-232021-08-25500,000— $0500,000SEC↗
IBIO iBio, Inc. A Award deriv2020-12-012020-12-02465,000— $0465,000SEC↗
IBIO iBio, Inc. A Award2020-12-012020-12-02309,000— $0309,000SEC↗
APVO Aptevo Therapeutics Inc. D To issuer deriv2020-07-272020-07-295,357— $00SEC↗
APVO Aptevo Therapeutics Inc. D To issuer deriv2020-07-272020-07-294,814— $00SEC↗
APVO Aptevo Therapeutics Inc. D To issuer deriv2020-07-272020-07-294,814— $00SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2020-07-272020-07-292,140— $02,140SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2020-07-272020-07-296,423— $06,423SEC↗
APVO Aptevo Therapeutics Inc. D To issuer deriv2020-07-272020-07-292,407— $00SEC↗
APVO Aptevo Therapeutics Inc. D To issuer deriv2020-07-272020-07-292,407— $00SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2020-02-182020-03-19134,800— $0134,800SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2019-11-012019-11-05122,359— $0122,359SEC↗
APVO Aptevo Therapeutics Inc. P Buy2019-08-162019-08-1925,000$0.76 $19.0K75,000SEC↗
APVO Aptevo Therapeutics Inc. P Buy2019-05-312019-06-0720,000$0.73 $14.6K50,000SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2019-02-282019-03-0467,400— $067,400SEC↗
APVO Aptevo Therapeutics Inc. P Buy2018-12-062018-12-075,000$2.37 $11.8K30,000SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2018-03-092018-03-1367,400— $067,400SEC↗
APVO Aptevo Therapeutics Inc. P Buy2017-11-152017-12-0825,000$2.76 $69.0K25,000SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2017-06-012017-06-0133,700— $033,700SEC↗
APVO Aptevo Therapeutics Inc. A Award deriv2017-02-242017-02-2733,700— $0108,700SEC↗